Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore additional resources to study natural toxins, pollutants including PFAS and 6-PPD-Q, and their biological effects.
ENVIRONMENTAL TOXICOLOGY TOOLS & SERVICESNatamycin is a tetraene macrolide that has been found in S. natalensis and has fungicidal activities.1,2,3 It is active against Fusarium, A. flavus, and A. fumigatus clinical isolates (MIC50s = 4, 32, and 2 µg/ml, respectively), and the plant pathogenic fungi B. cinerea and P. expansum when used at a concentration of 2 mg/L.1,2 Natamycin (100 and 200 mg/L, respectively) inhibits B. cinerea-induced gray mold disease in grapes and P. expansum-induced blue mold disease in jujube fruit.2 It reduces ulceration, edema, swelling, iritis, white blood cell accumulation, and loss of corneal transparency, as well as prevents F. solani-induced ocular keratitis, in a rabbit model of fungal keratitis.3 Formulations containing natamycin have been used in the treatment of fungal blepharitis, conjunctivitis, and keratitis, and as fungicides in agricultural settings and as food additives.
WARNING This product is not for human or veterinary use.
1. In vitro natamycin susceptibility of ocular isolates of Fusarium and Aspergillus species: Comparison of commercially formulated natamycin eye drops to pharmaceutical-
2. Effect of natamycin on Botrytis cinerea and Penicillium expansum—Postharvest pathogens of grape berries and jujube fruit. Postharvest Bio. Technol. 151, 134-141 (2019).
3. Antifungal efficacy of natamycin in experimental fusarium solani keratitis. Int. J. Ophthalmol. 5(2), 143-146 (2012).